- Panitumumab, sold
under the
brand name
Vectibix, is a
fully human monoclonal antibody specific to the
epidermal growth factor receptor (also
known as EGF...
-
Tezspire (tezepelumab-ekko)
Tavneos (avacopan)
Uplizna (inebilizumab)
Vectibix (panitumumab for
colon cancer) (FDA
approved 2006)
Xgeva (denosumab) for...
-
updated the
labels of two anti-EGFR
monoclonal antibody drugs (panitumumab (
Vectibix) and
cetuximab (Erbitux))
indicated for
treatment of
metastatic colorectal...
- KRAS
mutation was
predictive of a very poor
response to
panitumumab (
Vectibix) and
cetuximab (Erbitux)
therapy in
colorectal cancer. As of 2008, the...
-
research include: Copaxone,
Rebif (also
known as Avonex), Humira, Erbitux,
Vectibix, Enbrel, and Remicade. An
original method for non-matching bone marrow...
-
available in the market, such as
cetuximab (Erbitux) and
panitumumab (
Vectibix), both of
which are
directed against HER1. However,
cancer cells can switch...
-
Vaxigrip Vaxneuvance Vaxzevria Vazalore Vazculep Vazkepa vebufloxacin (INN)
Vectibix Vectical Vectrin vecuronium bromide (INN)
vedaclidine (INN) vedaprofen...
-
Colorectal cancer, Head and neck
cancer 2004
Bevacizumab (Avastin) VEGF Lung cancer,
Colorectal cancer 2004
Panitumumab (
Vectibix) EGFR
Colorectal cancer 2006...
- (CTGF)
idiopathic pulmonary fibrosis (IPF),
pancreatic cancer Panitumumab Vectibix mab
human epidermal growth factor receptor (EGFR) Y
colorectal cancer Pankomab...
-
humanized F
protein of RSV
Respiratory syncytial virus 103770 Link
panitumumab Vectibix Amgen 9/27/2006
intravenous fully human EGFR
Metastatic colorectal cancer...
